AU2001233080A1 - Modulation of tolerance by altering nfat signalling - Google Patents
Modulation of tolerance by altering nfat signallingInfo
- Publication number
- AU2001233080A1 AU2001233080A1 AU2001233080A AU3308001A AU2001233080A1 AU 2001233080 A1 AU2001233080 A1 AU 2001233080A1 AU 2001233080 A AU2001233080 A AU 2001233080A AU 3308001 A AU3308001 A AU 3308001A AU 2001233080 A1 AU2001233080 A1 AU 2001233080A1
- Authority
- AU
- Australia
- Prior art keywords
- altering
- tolerance
- modulation
- nfat signalling
- nfat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Marine Sciences & Fisheries (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17839900P | 2000-01-27 | 2000-01-27 | |
US60178399 | 2000-01-27 | ||
PCT/US2001/002850 WO2001055349A1 (en) | 2000-01-27 | 2001-01-29 | Modulation of tolerance by altering nfat signalling |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001233080A1 true AU2001233080A1 (en) | 2001-08-07 |
Family
ID=22652404
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001233080A Abandoned AU2001233080A1 (en) | 2000-01-27 | 2001-01-29 | Modulation of tolerance by altering nfat signalling |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2001233080A1 (en) |
WO (1) | WO2001055349A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050079496A1 (en) * | 2001-08-17 | 2005-04-14 | Edgar Serfling | Methods for diagnosing and treating neoplasias using nf-at transcriptions factors |
WO2004054506A2 (en) * | 2002-12-13 | 2004-07-01 | Irm Llc | Methods and compositions for modulating nf-at transcription factor |
JP2009502735A (en) * | 2005-07-28 | 2009-01-29 | オンコセラピー・サイエンス株式会社 | VIVIT polypeptide, therapeutic substance containing the same, and method for screening anticancer agent |
EP2323685A2 (en) * | 2008-07-11 | 2011-05-25 | Medizinische Universität Innsbruck | Agonists of nr2f6 for immunosuppression |
WO2013070943A2 (en) * | 2011-11-08 | 2013-05-16 | Children's Medical Center Corporation | Small molecule screen for inhibitors of nfat:ap-1:dna interactions |
CN112458149B (en) * | 2020-12-03 | 2021-10-08 | 北京东方百泰生物科技股份有限公司 | Method for detecting activation degree of antibody drug on T cells by taking CD3 as target |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0656067A4 (en) * | 1991-08-22 | 1995-10-25 | Univ Leland Stanford Junior | Screening methods for immunosuppressive agents. |
US6197925B1 (en) * | 1991-08-22 | 2001-03-06 | Sara Lee Corporation | NF-AT polypeptides and polynucleotides |
US5656452A (en) * | 1993-01-15 | 1997-08-12 | President And Fellows Of Harvard College | NF-ATp, ' a T lymphocyte DNA-binding protein |
-
2001
- 2001-01-29 AU AU2001233080A patent/AU2001233080A1/en not_active Abandoned
- 2001-01-29 WO PCT/US2001/002850 patent/WO2001055349A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2001055349A1 (en) | 2001-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001238513A1 (en) | Lubricated seals having micropores | |
AU2002213467A1 (en) | Modulation of ccr4 function | |
AU2001262507A1 (en) | Switching system | |
AU2002365827A1 (en) | Havi-upnp bridging | |
AU2001295758A1 (en) | Seal | |
AU2001290777A1 (en) | Intelligent voice bridging | |
AU2002348909A1 (en) | Havi-upnp bridging | |
AU2002241559A1 (en) | Switching system | |
AU2531301A (en) | Emergency lighting | |
AU2001292786A1 (en) | Sulfur-containing cathode | |
AU2002212445A1 (en) | Signalling means | |
AU2001233080A1 (en) | Modulation of tolerance by altering nfat signalling | |
AU2001271426A1 (en) | Modulation of apoptosis | |
AU2002223761A1 (en) | Thickening composition | |
AU2002211150A1 (en) | Traffic signalling | |
AUPR626701A0 (en) | Switching assembly | |
AU5508201A (en) | Moebius train | |
AU2002328209A1 (en) | Hierarchical modulation | |
AU2001278591A1 (en) | Switch assembly | |
AU2000268585A1 (en) | Phase modulator | |
AU2001256507A1 (en) | Modulation | |
AU2001258330A1 (en) | New uses of imidazolylmethyl-pyridines | |
AU2002313571A1 (en) | Fm modulator | |
AU2001274253A1 (en) | Signal modulation | |
AU7369701A (en) | Lighting assembly |